You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic lymphocytic leukemia, relapsed or with poor prognostic features.

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

Not yet recruiting
  • Relapsed/Refractory Chronic Lymphocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Jul 13, 2023

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +5 more
  • (no location specified)
Jul 21, 2023

Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

Active, not recruiting
  • Recurrent Chronic Lymphoid Leukemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

Active, not recruiting
  • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 20, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (pyrimethamine)

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Leukemia
  • Boston, Massachusetts
  • +1 more
Nov 14, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

Recruiting
  • Non-hodgkin Lymphoma
  • +2 more
  • CC312
  • Tianjin, Tianjin, China
    InstituteHBDH
Sep 12, 2023

Chronic Lymphocytic Leukemia (CLL) Trial

Completed
  • Chronic Lymphocytic Leukemia (CLL)
    • (no location specified)
    Apr 5, 2022

    B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • Cyclophosphamide injection
    • +2 more
    • Charleston, South Carolina
      Hollings Cancer Center at Medical University of South Carolina
    Jan 18, 2023

    Leukemia, Lymphoma, Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial (BGB-11417)

    Not yet recruiting
    • Leukemia
    • +4 more
    • (no location specified)
    Jul 27, 2022

    Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

    Recruiting
    • Non Hodgkin Lymphoma
    • +2 more
    • Fully human anti CD19 CAR-T Cell Dose
    • +2 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Oct 4, 2022

    Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

    Not yet recruiting
    • Relapsed Non-Hodgkin Lymphoma
    • +6 more
    • (no location specified)
    Apr 12, 2023

    Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma Trial in India (Acalabrutinib capsule)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma
    • Acalabrutinib capsule
    • Ahmedabad, India
    • +12 more
    Feb 2, 2023

    Relapsed Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Poland, United

    Recruiting
    • Relapsed Non Hodgkin Lymphoma
    • +6 more
    • Cincinnati, Ohio
    • +4 more
    Aug 3, 2022

    Chronic Lymphocytic Leukemia Trial in Salt Lake City (RP-3500 in combination with Olaparib)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • RP-3500 in combination with Olaparib
    • Salt Lake City, Utah
      Huntsman Cancer Institute at the University of Utah
    Sep 23, 2022

    Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving

    Recruiting
    • Chronic Lymphocytic Leukemia
      • Granada, Spain
      • +4 more
      Nov 8, 2023

      Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

      Active, not recruiting
      • Prolymphocytic Leukemia
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 7, 2022

      Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Small

      Recruiting
      • Recurrent Chronic Lymphocytic Leukemia
      • +4 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Mar 22, 2022

      Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

      Recruiting
      • Chronic Lymphocytic Leukemia
      • +4 more
        • Bobigny, France
        • +8 more
        Mar 23, 2022

        Chronic Lymphocytic Leukemia Trial in Lebanon (BNC105P, Ibrutinib)

        Completed
        • Chronic Lymphocytic Leukemia
        • BNC105P
        • Ibrutinib
        • Lebanon, New Hampshire
          Dartmouth-Hitchcock Medical Center
        Jan 3, 2023

        Chronic Lymphocytic Leukemia Trial in Poland, United Kingdom (Ceralasertib, Acalabrutinib)

        Active, not recruiting
        • Chronic Lymphocytic Leukemia
        • Kraków, Poland
        • +10 more
        Dec 2, 2022

        Relapsed Chronic Lymphocytic Leukemia Trial in Ann Arbor (Metformin)

        Recruiting
        • Relapsed Chronic Lymphocytic Leukemia
        • Ann Arbor, Michigan
          University of Michigan Comprehensive Cancer Center
        May 11, 2022

        Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in

        Recruiting
        • Autoimmune Hemolytic Anemia
        • +3 more
        • Duarte, California
          City of Hope Medical Center
        Mar 9, 2022